Pantoprazole Zentiva (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Pantoprazole Zentiva, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage conditions such as gastro‑oesophageal reflux disease, erosive esophagitis and peptic ulcer disease in adults.

GNH USA supplies Pantoprazole Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor indicated for several acid‑related gastrointestinal disorders. - Gastro‑oesophageal reflux disease (GERD): reduces stomach acid to relieve heartburn and regurgitation. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea: occasional stomach upset. - Abdominal pain: cramp‑like discomfort. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: severe diarrhea, abdominal pain. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Elevated liver enzymes: signs of liver irritation. - Stevens‑Johnson syndrome: skin blistering and detachment. - Pancreatitis: upper abdominal pain, nausea, vomiting.

Before initiating therapy, consider the following safety measures. - Assess renal function: adjust use in severe impairment. - Monitor for infection: prolonged therapy may increase risk of C. difficile. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in elderly: higher incidence of fractures and bone loss. - Pregnancy and lactation: discuss risks and benefits with prescriber. - Store at ambient temperature: keep in original container, protect from moisture.

Pantoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, reducing antiviral efficacy. - High‑dose methotrexate: increased toxicity due to reduced clearance.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer monitoring. - Digoxin: may raise serum levels, watch for signs of toxicity. - Diazepam: potential increase in plasma concentration, monitor sedation.